These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31618701)

  • 1. Strategies for stabilizing formulation and QbD assisted development of robust stability indicating method of azilsartan medoxomil/chlorthalidone.
    Gad MA; Amer SM; Zaazaa HE; Hassan SA
    J Pharm Biomed Anal; 2020 Jan; 178():112910. PubMed ID: 31618701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability-Indicating RP-UPLC Method for Simultaneous Determination of Azilsartan Medoxomil and Chlorthalidone in Tablets in the Presence of Its Degradation Products.
    Hussein LA; Magdy NN; Ibrahim MA
    J Chromatogr Sci; 2019 Mar; 57(3):213-219. PubMed ID: 30395199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability-indicating RP-LC method for determination of azilsartan medoxomil and chlorthalidone in pharmaceutical dosage forms: application to degradation kinetics.
    Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
    Anal Bioanal Chem; 2014 Oct; 406(26):6701-12. PubMed ID: 25190009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of azilsartan and chlorthalidone in rat and human plasma by liquid chromatography-electrospray tandem mass spectrometry.
    Ramakrishna R; Puttrevu SK; Bhateria M; Bala V; Sharma VL; Bhatta RS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():185-97. PubMed ID: 25899870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemometry and Green Chemistry-Based Chromatographic Analysis of Azilsartan Medoxomil, Cilnidipine and Chlorthalidone in Human Plasma Using Analytical Quality by Design Approach.
    Prajapati P; Shahi A; Acharya A; Shah S
    J Chromatogr Sci; 2024 Mar; 62(3):201-212. PubMed ID: 35942542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography/tandem mass spectrometry study of forced degradation of azilsartan medoxomil potassium.
    Swain D; Patel PN; Palaniappan I; Sahu G; Samanthula G
    Rapid Commun Mass Spectrom; 2015 Aug; 29(15):1437-47. PubMed ID: 26147484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of RP-HPLC method for the simultaneous determination of azilsartan medoxomil and chlorthalidone in solid dosage form.
    Muhammad Jahangir -; Arooj Azhar -; Aymen Awan -
    Pak J Pharm Sci; 2023 Jul; 36(4):1053-1061. PubMed ID: 37599478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic modeling of the antihypertensive interaction between azilsartan medoxomil and chlorthalidone in spontaneously hypertensive rats.
    Kumar Puttrevu S; Ramakrishna R; Bhateria M; Jain M; Hanif K; Bhatta RS
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):457-470. PubMed ID: 28190245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review.
    Katsi V; Michalakeas C; Soulaidopoulos S; Antonopoulos AS; Vlachopoulos C; Tousoulis D; Tsioufis K
    Curr Hypertens Rev; 2021; 17(3):217-227. PubMed ID: 33438552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Composite Design Expert-Supported RP-HPLC Optimization and Quantitative Evaluation of Efonidipine Hydrochloride Ethanolate & Chlorthalidone in Tablet.
    Patel BD; Vekaria HJ
    J Chromatogr Sci; 2024 Jul; 62(6):585-592. PubMed ID: 37747353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QbD-based development of an extraction procedure for simultaneous quantification of telmisartan, amlodipine besylate and chlorthalidone in combination complex matrix formulation.
    Palakurthi AK; Dongala T; Yalavarthi RK; Anireddy J
    Biomed Chromatogr; 2020 Feb; 34(2):e4755. PubMed ID: 31755118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive.
    Pierini D; Anderson KV
    Ann Pharmacother; 2013 May; 47(5):694-703. PubMed ID: 23585646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
    Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride and chlorthalidone.
    El-Gindy A; Emara S; Mostafa A
    Farmaco; 2005 Mar; 60(3):269-78. PubMed ID: 15784248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Estimating Olmesartan Medoxomil Using Quality by Design.
    Beg S; Sharma G; Katare OP; Lohan S; Singh B
    J Chromatogr Sci; 2015 Aug; 53(7):1048-59. PubMed ID: 25583970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
    Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
    Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed-Dose Combination in Healthy Adults.
    Dudkowski C; Karim A; Munsaka M
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):393-8. PubMed ID: 27514506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated stability-indicating methods for the simultaneous determination of amiloride hydrochloride, atenolol, and chlorthalidone using HPTLC and HPLC with photodiode array detector.
    Youssef RM; Maher HM; El-Kimary EI; Hassan EM; Barary MH
    J AOAC Int; 2013; 96(2):313-23. PubMed ID: 23767356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and
    Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rapid Novel HPLC Method for Estimation of Eight Related Compounds in Azilsartan Kamedoxomil and Identification of Degradation Compounds by Using LC-MS.
    Sreenivasulu J; Venkata Ramana P; Sampath Kumar Reddy G; Nagaraju ChV; Thirumalai Rajan S; Eswaraiah S
    J Chromatogr Sci; 2015 Oct; 53(9):1463-74. PubMed ID: 25925084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.